Advance Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.50 Cr
- Revenue Growth -9.13%
- Profit Growth 57.86%
- Ebitda 74.76%
- Net Worth -0.69%
- Total Assets -2.38%
About Advance Therapeutics
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33112DL2002PTC113960
-
Company No.
113960
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jan 2002
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Advance Therapeutics?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gurmit Chugh
![]() |
Managing Director | 01-Apr-2004 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Punita Sharma
![]() |
Director | 01-Apr-2004 | Current |
Financial Performance of Advance Therapeutics.
Advance Therapeutics Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.13% decrease. The company also saw a substantial improvement in profitability, with a 57.86% increase in profit. The company's net worth dipped by a decrease of 0.69%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Advance Therapeutics?
In 2022, Advance Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹0
₹55.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 5.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
03 Aug 2007 | Hdfc Bank Limited | ₹5.50 Cr | Satisfied |
How Many Employees Work at Advance Therapeutics?
Unlock and access historical data on people associated with Advance Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Advance Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advance Therapeutics's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.